Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
-2°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cybin Inc. Common Shares
(NY:
CYBN
)
9.530
+0.060 (+0.63%)
Official Closing Price
Updated: 8:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cybin Inc. Common Shares
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
39
40
Next >
Cybin Stock Down On Laying Off 15% Of Workforce As Part Of A Streamlining Clinical Alignment
February 23, 2023
Cybin Inc. (NEO:CYBN) (AMEX:CYBN) announced Thursday a streamlining plan aimed at maximizing the company’s operating efficiency and allowing it to focus on critical clinical trials.
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Plan to Streamline Efforts, Maximize Efficiency, Focus on Clinical Trials
February 23, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Psychedelic Stock Gainers And Losers From February 22, 2023
February 22, 2023
Via
Benzinga
Cybin Announces Streamlined Clinical Alignment
February 22, 2023
From
Cybin Inc.
Via
Business Wire
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and...
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 21, 2023
February 21, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 20, 2023
February 20, 2023
Via
Benzinga
"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio YTD By A 2-To-1 Margin
February 19, 2023
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. Perhaps some will bounce back with
Via
Talk Markets
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD
February 17, 2023
A look at the performance of the six largest psychedelic stocks by market capitalization.
Via
Talk Markets
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today
February 17, 2023
Via
Benzinga
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today
February 16, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 15, 2023
February 15, 2023
Via
Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
February 14, 2023
Via
Benzinga
Cybin Reports Q3 Earnings, Says Psilocybin Tial Is Progressing As MDD Treatment
February 14, 2023
Cybin Inc. (NYSE: CYBN) has shared its unaudited financial results for the third quarter that ended Dec. 31, 2022. The company held total cash of $16.9 (CA$22.5) million as of Dec. 31, 2022, and $15...
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Q3 Financial Report, Corporate Highlights
February 14, 2023
Via
Investor Brand Network
Cybin Inc. Reports Third Quarter Financial Results and Recent Business Highlights
February 14, 2023
From
Cybin Inc.
Via
Business Wire
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
February 13, 2023
Via
Benzinga
"Multi-Bagger" Portfolio Update
February 12, 2023
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. I'm tracking 12 microcap stocks that might bounce back with major returns - dare I say
Via
Talk Markets
Major Psychedelic Compound-Based Stocks UP 13% YTD
February 11, 2023
We track the performance of the 6 largest companies researching the treatment of mental illnesses based on the use of one or more of 10 different psychedelic compound-based substances.
Via
Talk Markets
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
February 10, 2023
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
February 09, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 8, 2023
February 08, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 7, 2023
February 07, 2023
Via
Benzinga
The "Multi-Bagger" Portfolio Continued To Outperform The S&P 500 Last Week
February 06, 2023
Our basket of mostly microcap cannabis, psychedelic and plant-based food stocks was extremely oversold in 2022 but we're watching for them to bounce back in 2023.
Via
Talk Markets
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
February 06, 2023
Via
Benzinga
The 7 Most Promising Psychedelic Stocks to Buy in February
February 05, 2023
These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector.
Via
InvestorPlace
6 Largest Psychedelic Stocks Down 3% This Week
February 04, 2023
The six largest of the 40 companies researching the treatment of mental illnesses by using psychedelic substances, which constitute our Psychedelic Drug Stocks Index, are now up 13% YTD despite a loss...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From February 3, 2023
February 03, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 2, 2023
February 02, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 1, 2023
February 01, 2023
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
39
40
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
